Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pulmonology · Pulmonary Mycobacterium avium complex disease

Can You Have Pulmonary MAC With a Negative AFB Smear?

At a Glance

Yes. Pulmonary MAC can be present even when an AFB smear is negative because the smear may miss small amounts of bacteria. Doctors combine symptoms, chest CT findings, and sputum culture results, sometimes using bronchoscopy, to establish the diagnosis.

Yes, it is entirely possible to have pulmonary Mycobacterium avium complex (MAC) disease even if your AFB smear is negative. A negative smear does not rule out MAC, and it should not be the only test used to determine if you have an infection [1].

To understand why this happens, it is helpful to know the difference between an AFB smear and a sputum culture. An AFB (acid-fast bacillus) smear involves placing a sample of your sputum (phlegm) on a slide, staining it with a special dye, and looking at it under a microscope. This test detects any “acid-fast” bacteria, but it cannot specifically identify MAC or distinguish it from other similar bacteria. The smear is a fast test, but it is not highly sensitive. For the smear to be positive, the amount of bacteria in the sample must be above a certain detection threshold [2].

A culture, on the other hand, involves taking your sputum sample and putting it in an environment that encourages bacteria to grow. Because a culture allows a small number of bacteria to multiply into a detectable amount, it is generally much more sensitive than a smear. It can detect organisms even when there are too few to be seen under a microscope. Once bacteria grow in the culture, further testing is done to identify the exact species (such as MAC). Because MAC bacteria grow very slowly, cultures can take several weeks to yield a result.

How a Diagnosis is Established

If your AFB smear is negative but your doctor suspects MAC, they will look at the broader picture [3]. Simply finding MAC in a single sputum sample does not automatically mean you have an active infection; the bacteria could just be temporarily present in your airways. A formal diagnosis of pulmonary MAC requires a combination of clinical, imaging, and microbiologic evidence:

  • Clinical Symptoms: You must have compatible symptoms, such as chronic cough, fatigue, shortness of breath, or weight loss, and other potential causes must be ruled out.
  • Imaging Findings: A high-resolution CT scan of your chest is used to look for characteristic signs, such as bronchiectasis (widened and damaged airways), small nodules, or cavities (holes in the lung tissue) [4][5]. Progressive changes on a CT scan over time can also increase clinical concern for an active infection [6].
  • Microbiology: To confirm the presence of MAC, your doctor will usually look for at least two positive sputum cultures from separate samples [7][8]. Providing a good quality sample from deep in your lungs (not just saliva) is important. If you cannot cough up enough sputum, they might use inhaled saline to induce a cough (induced sputum).
  • Bronchoscopy: If sputum tests are repeatedly negative or you cannot produce sputum, your doctor may consider a bronchoscopy [9]. In this invasive procedure, a thin tube is passed into your lungs to collect fluid (a bronchial wash or lavage). Just one positive culture from a bronchoscopy can meet the microbiologic criteria for diagnosis [10].

What Smear Status Tells Us

While a negative smear does not rule out MAC, knowing your smear status is helpful. A positive smear generally indicates a higher amount of bacteria in your sputum [11].

However, your disease severity and prognosis are not determined by smear status alone. Your care team will evaluate the extent of changes on your CT scan, whether you have cavities in your lungs, your lung function, and the severity of your symptoms [12][4].

It is also important to know that even if you are officially diagnosed with pulmonary MAC, immediate antibiotic treatment is not always required. Because treatment is long and can have side effects, your doctor may recommend a period of “watchful waiting” to monitor your symptoms and repeat testing before deciding if medications are necessary [13].

Common questions in this guide

Can pulmonary MAC still be present if my AFB smear is negative?
Yes. A negative AFB smear means the sample did not contain enough acid-fast bacteria to be seen under a microscope; it does not rule out pulmonary MAC. Sputum cultures and the rest of the clinical evaluation are still important.
Why can a sputum culture find MAC when a smear does not?
A smear checks the sample directly under a microscope and may miss a small number of bacteria. A culture gives bacteria time to multiply and then allows the laboratory to identify the specific organism, such as MAC. Because MAC grows slowly, culture results may take several weeks.
How is pulmonary MAC diagnosed after a negative smear?
Doctors combine compatible symptoms, chest CT findings, and microbiology results. Usually, they look for at least two positive cultures from separate sputum samples; induced sputum or bronchoscopy may be considered if sputum cannot be obtained or remains negative. One positive culture from a bronchoscopy can meet the microbiologic part of diagnosis when the other evidence fits.
What does a negative AFB smear say about how serious pulmonary MAC is?
A negative smear often means there are fewer bacteria in that particular sputum sample, but it does not determine disease severity or prognosis by itself. Doctors also consider the extent of CT changes, cavities, lung function, symptoms, and whether the disease is progressing.
Does a negative smear mean I do not need treatment for pulmonary MAC?
No. Treatment decisions consider symptoms, CT findings, cavities, lung function, and the overall extent of disease, so a negative smear alone does not decide whether treatment is needed. Because antibiotic treatment can be lengthy and cause side effects, some people are monitored with watchful waiting before starting medication.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do we have the results of my sputum cultures yet, or are we still waiting for them to grow?
  2. 2.Did the culture identify MAC specifically, and do my results meet the formal criteria for MAC disease?
  3. 3.If my expectorated sputum cultures are negative, should we try induced sputum or a bronchoscopy?
  4. 4.Based on my symptoms and CT scan, how extensive are the lung changes, and are there signs of bronchiectasis or cavities?
  5. 5.Does my negative smear status, combined with my imaging, suggest we should start treatment now or monitor my condition closely?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    The characteristics of patients with pulmonary Mycobacterium avium-intracellulare complex disease diagnosed by bronchial lavage culture compared to those diagnosed by sputum culture.

    Maekawa K, Naka M, Shuto S, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017; (23(9)):604-608 doi:10.1016/j.jiac.2017.05.008.

    PMID: 28606745
  2. 2

    Risk factors for clinical progression in patients with pulmonary Mycobacterium avium complex disease without culture-positive sputum: a single-center, retrospective study.

    Nonaka M, Matsuyama M, Sakai C, et al.

    European journal of medical research 2023; (28(1)):186 doi:10.1186/s40001-023-01152-0.

    PMID: 37291649
  3. 3

    Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

    Daley CL, Iaccarino JM, Lange C, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (71(4)):905-913 doi:10.1093/cid/ciaa1125.

    PMID: 32797222
  4. 4

    Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.

    Jhun BW, Moon SM, Jeon K, et al.

    The European respiratory journal 2020; (55(1)) doi:10.1183/13993003.00798-2019.

    PMID: 31619468
  5. 5

    Predictors of radiological aggravations of pulmonary MAC disease.

    Kodaka N, Nakano C, Oshio T, et al.

    PloS one 2020; (15(8)):e0237071 doi:10.1371/journal.pone.0237071.

    PMID: 32760104
  6. 6

    Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment.

    Park TY, Chong S, Jung JW, et al.

    PloS one 2017; (12(10)):e0185774 doi:10.1371/journal.pone.0185774.

    PMID: 28968457
  7. 7

    Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates.

    Ghio AJ, Smith GS, DeFlorio-Barker S, et al.

    Journal of clinical tuberculosis and other mycobacterial diseases 2019; (17()):100133 doi:10.1016/j.jctube.2019.100133.

    PMID: 31867444
  8. 8

    Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

    Daley CL, Iaccarino JM, Lange C, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (71(4)):e1-e36 doi:10.1093/cid/ciaa241.

    PMID: 32628747
  9. 9

    Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease.

    Shimada D, Sagawa M, Seki M

    Infection and drug resistance 2023; (16()):977-984 doi:10.2147/IDR.S400200.

    PMID: 36824065
  10. 10

    The diagnostic yield and characteristics of bronchoalveolar lavage in suspected nontuberculous mycobacterial pulmonary disease.

    Kajikawa S, Fujishiro E, Kato T, et al.

    International journal of mycobacteriology 2022; (11(3)):236-240 doi:10.4103/ijmy.ijmy_77_22.

    PMID: 36260440
  11. 11

    Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.

    Pasipanodya JG, Ogbonna D, Deshpande D, et al.

    The Journal of antimicrobial chemotherapy 2017; (72(suppl_2)):i3-i19 doi:10.1093/jac/dkx311.

    PMID: 28922813
  12. 12

    Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.

    Koh WJ, Moon SM, Kim SY, et al.

    The European respiratory journal 2017; (50(3)) doi:10.1183/13993003.02503-2016.

    PMID: 28954780
  13. 13

    Nontuberculous Mycobacteria: Diagnosis and Therapy.

    Varley CD, Winthrop KL

    Clinics in chest medicine 2022; (43(1)):89-98 doi:10.1016/j.ccm.2021.11.007.

    PMID: 35236564

This page explains what a negative AFB smear can and cannot show about pulmonary MAC for informational purposes only; it does not constitute medical advice. Ask your clinician to interpret your cultures, CT findings, symptoms, and treatment options.

Get notified when new evidence is published on Mycobacterium avium complex disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.